S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
Log in
LON:AMYT

Amryt Pharma Share Forecast, Price & News

GBX 208
-6.00 (-2.80 %)
(As of 02/25/2021 08:15 AM ET)
Add
Compare
Today's Range
208
Now: GBX 208
208
50-Day Range
190
MA: GBX 204.93
222
52-Week Range
80
Now: GBX 208
250
Volume62 shs
Average Volume43,478 shs
Market Capitalization£371.91 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Amryt Pharma plc, a biopharmaceutical company, develops and commercializes therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy. It also develops FILSUVEZ drug candidate for the treatment of severe epidermolysis bullosa (EB), a rare and genetic skin disease; and AP103 for the treatment of patients with recessive dystrophic EB, a subset of EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is based in London, the United Kingdom.
Amryt Pharma logo

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-34155730
Employees169
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£180.38 million
Cash FlowGBX 44.52 per share
Book ValueGBX 45.80 per share

Profitability

Miscellaneous

Market Cap£371.91 million
Next Earnings Date3/4/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.50 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
GBX 208
-6.00 (-2.80 %)
(As of 02/25/2021 08:15 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AMYT News and Ratings via Email

Sign-up to receive the latest news and ratings for AMYT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Amryt Pharma (LON:AMYT) Frequently Asked Questions

What stocks does MarketBeat like better than Amryt Pharma?

Wall Street analysts have given Amryt Pharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Amryt Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Amryt Pharma's next earnings date?

Amryt Pharma is scheduled to release its next quarterly earnings announcement on Thursday, March 4th 2021.
View our earnings forecast for Amryt Pharma
.

How has Amryt Pharma's stock been impacted by COVID-19 (Coronavirus)?

Amryt Pharma's stock was trading at GBX 104 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AMYT stock has increased by 100.0% and is now trading at GBX 208.
View which stocks have been most impacted by COVID-19
.

Who are Amryt Pharma's key executives?

Amryt Pharma's management team includes the following people:
  • Dr. Joseph A. Wiley, CEO & Director (Age 50, Pay $1.72M)
  • Mr. Rory P. Nealon, CFO, COO & Company Sec. (Age 53, Pay $931k)
  • Mr. Stephen Joyce, VP of Global Marketing
  • Ms. Julie Eastwood, Head of HR
  • Ms. Derval O'Carroll, Head of Regulatory Affairs
  • Mr. Gerry Gilligan, Head of Manufacturing Supply Chain
  • Dr. Mark Sumeray, Chief Medical Officer (Age 55)
  • Mr. David Allmond, Chief Commercial Officer
  • Dr. Helen Phillips, Head of Medical Affairs

Who are some of Amryt Pharma's key competitors?

What other stocks do shareholders of Amryt Pharma own?

What is Amryt Pharma's stock symbol?

Amryt Pharma trades on the London Stock Exchange (LON) under the ticker symbol "AMYT."

How do I buy shares of Amryt Pharma?

Shares of AMYT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Amryt Pharma's stock price today?

One share of AMYT stock can currently be purchased for approximately GBX 208.

How much money does Amryt Pharma make?

Amryt Pharma has a market capitalization of £371.91 million and generates £180.38 million in revenue each year.

How many employees does Amryt Pharma have?

Amryt Pharma employs 169 workers across the globe.

What is Amryt Pharma's official website?

The official website for Amryt Pharma is www.amrytpharma.com.

Where are Amryt Pharma's headquarters?

Amryt Pharma is headquartered at Ivybridge House, 1 Adam Street, LONDON, WC2N 6LE, United Kingdom.

How can I contact Amryt Pharma?

Amryt Pharma's mailing address is Ivybridge House, 1 Adam Street, LONDON, WC2N 6LE, United Kingdom. The company can be reached via phone at +44-20-34155730.


This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.